Back

Early in-hospital initiation of SGLT2 inhibitors in acute decompensated heart failure

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure 1 Treatment HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Luis Eduardo Echeverria

Foundation Cardiovascular of Colombia, Floridablanca (Colombia)

3 More presentations in this session

Presentation thumbnail
Lung ultrasound in acute heart failure: a head-to-head comparison with other modalities to detect pulmonary congestion
Doctor K. Miger (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Short-term echocardiographic and biomarker changes in de-novo heart failure versus acutely decompensated chronic heart failure
Doctor H. Hussein (Coventry, GB)
Abstract Slides Video
Presentation thumbnail
Pulmonary artery catheterization in cardiogenic shock: a propensity matched analysis on management and prognostic impact
Doctor A. Bello (Carnaxide, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: a meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
SGLT2i treatment at the beginning of real time exposure in a HFrEF population
thumbnail
Congress Presentation
The impact of early SGLT2i inclusion in quadruple therapy for de novo patients: enhancing medication management and clinical outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources